Yongyan Cui

Yongyan Cui practices at Virginia Mason Medical Center - HOPD in Seattle, Washington.

Yongyan Cui's NPI, 1265895825, was assigned on March 31, 2016. Yongyan Cui graduated from Renaissance School of Medicine at Stony Brook University in 2016. Yongyan Cui holds California license A186244.

Yongyan Cui's primary practice is Virginia Mason Medical Center - HOPD, at 1100 9th Ave, Seattle, WA 98101.

Yongyan Cui's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Yongyan Cui is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Yongyan Cui to 4 more hospitals, 1 group practice or clinic and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yongyan Cui practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Yongyan Cui's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Yongyan Cui is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Yongyan Cui's licenses on file in 3 states: California, Washington and New York.

Dmand AI lists colonoscopy and upper GI endoscopy among the conditions Yongyan Cui treats.

CMS data shows 409 Medicare services from Yongyan Cui across 10 procedure codes in 2024, for 192 Medicare patients. Medicare paid $53,652 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Yongyan Cui in 2024. The largest group is 65 to 74, with 95 patients. 74% of them have high blood pressure, and 73% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Yongyan Cui's median patient age at 66, with 48% women.

In 2024, Yongyan Cui wrote 70 Medicare Part D claims for 54 patients. 99% of them were for generic drugs. CMS names the drug for 53 of them, across 2 drugs with 11 or more claims each, at $218 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

Yongyan Cui accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 751 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Yongyan Cui, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Yongyan Cui, published from 2011 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Colonoscopy and Endoscopes. Yongyan Cui has published most often in Gastrointest Endosc. Yongyan Cui's most frequent co-authors are Seth Andrew Gross, MD, Shayan Irani, MD and John Dennis Allendorf, MD.

Dmand AI links Yongyan Cui to 1 clinical trial.

CMS Open Payments shows 27 general payments to Yongyan Cui from 6 drug and device companies from 2022 to 2024. Grants make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $15,001.

Yongyan Cui graduated from Renaissance School of Medicine at Stony Brook University in 2016.

Yongyan Cui is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.